Journal article
Gamma Secretase Inhibitors in Cancer: A Current Perspective on Clinical Performance
The oncologist (Dayton, Ohio), Vol.26(4), pp.e608-e621
04/2021
DOI: 10.1002/onco.13627
PMID: 33284507
Abstract
This review focuses on the current understanding of gamma secretase inhibitors (GSI), as well as clinical performance to date and areas for future investigation that might maximize the utility of these agents.
Details
- Title: Subtitle
- Gamma Secretase Inhibitors in Cancer: A Current Perspective on Clinical Performance
- Creators
- Tyler R. McCaw - University of Alabama at BirminghamEvelyn Inga - University of Alabama at BirminghamHerbert Chen - University of Alabama at BirminghamRenata Jaskula-Sztul - University of Alabama at BirminghamVikas Dudeja - University of Alabama at BirminghamJames A. Bibb - University of Alabama at BirminghamBin Ren - University of Alabama at BirminghamJ. Bart Rose - University of Alabama at Birmingham
- Resource Type
- Journal article
- Publication Details
- The oncologist (Dayton, Ohio), Vol.26(4), pp.e608-e621
- DOI
- 10.1002/onco.13627
- PMID
- 33284507
- NLM abbreviation
- Oncologist
- ISSN
- 1083-7159
- eISSN
- 1549-490X
- Publisher
- John Wiley & Sons, Inc
- Alternative title
- Current Performance of GSIs in Cancer
- Language
- English
- Date published
- 04/2021
- Academic Unit
- Anatomy and Cell Biology; Surgery
- Record Identifier
- 9985244575902771
Metrics
1 Record Views